Tolerance Bio will increase health span by preserving, restoring, AND MANIPULATING the function of the thymus, the master regulator of immune tolerance News & UPDATES Featured Dec 19, 2024 Tolerance Bio, Inc. Announces Scientific Advisory Board and Completion of $20.2 Million Seed Round to Advance Thymus-Based Therapies for Immune-Mediated Diseases Dec 19, 2024 Read More → Dec 19, 2024 Oct 15, 2024 Tolerance Bio, Inc. Launches with $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases Oct 15, 2024 Read More → Oct 15, 2024
